Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 224-631-8 | CAS number: 4431-83-8
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics
- Type of information:
- other: statement
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Based on Physical and Chemical properties
Data source
Reference
- Reference Type:
- other: statement
- Title:
- Toxicokinetics statement
- Author:
- Anonymous
- Year:
- 2 013
Materials and methods
Results and discussion
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- Oral / gastrointestinal absorption
With a low molecular weight (164.20 g/mol), high water solubility (1000 g/L) and log Kow of -0.69, oral/gastrointestinal absorption of TOU is favoured subsequent to oral ingestion. Log Kow values between -1 and 4 are favourable for absorption by passive diffusion.
Inhalation absorption
TOU is a substance with a medium volatility but may be available for inhalation as a vapour. Its moderate log Kow value is favourable for absorption directly across the respiratory tract epithelium by passive diffusion. High solubility of TOU in water indicates that it may be retained within the mucus.
Dermal absorption
As a liquid with a molecular weight close to 100 g/mol, TOU dermal uptake is favoured.
Based on molecular weight < 500 and log Kow in the (-1, 4) range, default dermal absorption of TOU is set to 100% for risk assessment. - Details on distribution in tissues:
- A wide distribution is expected due to the low molecular weight. As a small water-soluble molecule, TOU is going to diffuse through aqueous channels and pores.
- Details on excretion:
- TOU is not considered as substance with a potential to accumulate within the body. The liver is known to be the greatest capacity for metabolism and the 28-day dermal study shows no significant increases in liver weights of male and female rats exposed to 1000 mg/kg bw/d of TOU.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): no bioaccumulation potential based on study results
The following values for absorption assessment were taken into account according to TOU behaviour (absorption, metabolism, distribution and elimination):
oral absorption of TOU is set to 100% for risk assessment;
inhalation absorption of TOU is set to 100% for risk assessment;
dermal absorption of TOU is set to 100% for risk assessment.
At more, no bioaccumulation potentiel is expected due to the low log Kow value of the test item. - Executive summary:
ABSORPTION
Oral / gastrointestinal absorption
With a low molecular weight (164.20 g/mol), high water solubility (1000 g/L) and log Kow of -0.69, oral/gastrointestinal absorption of TOU is favoured subsequent to oral ingestion. Log Kow values between -1 and 4 are favourable for absorption by passive diffusion.
Oral absorption of TOU is set to 100% for risk assessment
Inhalation absorption
TOU is a substance with a medium volatility but may be available for inhalation as a vapour. Its moderate log Kow value is favourable for absorption directly across the respiratory tract epithelium by passive diffusion. High solubility of TOU in water indicates that it may be retained within the mucus.
Inhalation absorption of TOU is set to 100% for risk assessment
Dermal absorption
As a liquid with a molecular weight close to 100 g/mol, TOU dermal uptake is favoured.
Based on molecular weight < 500 and log Kow in the (-1, 4) range, default dermal absorption of TOU is set to 100% for risk assessment.
Dermal absorption of TOU is set to 100% for risk assessment
DISTRIBUTION
A wide distribution is expected due to the low molecular weight. As a small water-soluble molecule, TOU is going to diffuse through aqueous channels and pores.
METABOLISM and EXCRETION
TOU is not considered as substance with a potential to accumulate within the body. The liver is known to be the greatest capacity for metabolism and the 28-day dermal study shows no significant increases in liver weights of male and female rats exposed to 1000 mg/kg bw/d of TOU.
The following values for absorption assessment were taken into account according to TOU behaviour (absorption, metabolism, distribution and elimination):
oral absorption of TOU is set to 100% for risk assessment;
inhalation absorption of TOU is set to 100% for risk assessment;
dermal absorption of TOU is set to 100% for risk assessment.
At more, no bioaccumulation potentiel is expected due to the low log Kow value of the test item.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
